Technology in the field of wound management is constantly progressing as researchers search for the ideal wound dressing. The regulatory situation for wound-care products can be confusing because in some cases they are considered to be pharmaceuticals and in others they are deemed to be medical devices. In addition, the situation has not been assisted by the system of risk classification in the Medical Device Directive. This article highlights the issues and provides an update on the latest position.